Journal of gynecologic oncology

J Gynecol Oncol · ISSN (e) 2005-0399 · 88 papers in corpus
2026
doi:10.3802/jgo.2026.37.e78 ·PMID:41834412

ObjectiveThis study aims to update the latest epidemiology of ovarian cancer.MethodsIncidence and mortality data of ovarian cancer were extracted from 2 databases, the GLOBOCAN 2022 and the Global Burden of Disease 2021, to analyze age-stan…

2026
doi:10.3802/jgo.2026.37.e18 ·PMID:40968749

ObjectiveIntraoperative frozen section examination is crucial for confirming the oncological safety of radical abdominal trachelectomy (RAT) for early-stage cervical cancer. This study evaluated the diagnostic accuracy of frozen section dur…

2026
doi:10.3802/jgo.2026.37.e24 ·PMID:41575337

ObjectiveThe treatment effects of lymphadenectomy in early-stage ovarian clear cell carcinoma (OCCC) reported in previous studies may have been overestimated owing to confounding factors. This study aimed to investigate the treatment effect…

2026
doi:10.3802/jgo.2026.37.e88 ·PMID:41906784

ObjectiveTo investigate the prevalence of high-risk human papillomavirus (hrHPV) infection and its association with cervicovaginal microbiome (CVM) diversity among young Korean women who received human papillomavirus (HPV) vaccination.Metho…

2026
doi:10.3802/jgo.2026.37.e121 ·PMID:42252253

The fallopian tube has emerged as a central organ in the pathogenesis of ovarian cancer, particularly high-grade serous carcinoma (HGSC). Detailed histopathological and molecular analyses have revealed a diverse spectrum of tubal epithelial…

2025
doi:10.3802/jgo.2025.36.e104 ·PMID:40350707

ObjectiveMedroxyprogesterone acetate (MPA) is an effective fertility-preserving treatment for early endometrial cancer and atypical endometrial hyperplasia (AEH), and rarely leads to the development of extrauterine lesions (ELs). We aimed t…

2025
doi:10.3802/jgo.2025.36.e107 ·PMID:40275684

Informed consent is a fundamental aspect of surgical care, designed to reinforce patient autonomy, promote shared decision-making, and potentially mitigate legal conflicts by ensuring the provision of comprehensive and consistent informatio…

2025
doi:10.3802/jgo.2025.36.e93 ·PMID:40150911

ObjectiveThis multi-center retrospective study aimed to clarify the characteristics, diagnostic accuracy, treatment outcomes, and prognostic factors of uterine serous carcinoma (USC) in Japanese women.MethodsThe medical records of 193 patie…

2025
doi:10.3802/jgo.2025.36.e30 ·PMID:39344149

ObjectiveThis study aimed to assess the diagnostic performance of the Risk of Ovarian Malignancy Algorithm (ROMA), Copenhagen Index (CPH-I), and Ovarian Adnexal Reporting and Data System (O-RADS) for the preoperative prediction of ovarian c…

2025
doi:10.3802/jgo.2025.36.e128 ·PMID:40613115

ObjectiveWe aimed to identify the main oncogenic pathway by histological type of ovarian cancer based on Next-generation sequencing (NGS) test and to determine the correlation with clinical prognosis.MethodsWe conducted a retrospective revi…

other 2025
doi:10.3802/jgo.2025.36.e54 ·PMID:39791511

OBJECTIVE: To explore the characteristics and survival outcomes of ovarian squamous cell carcinoma (SCC) and the treatment effectiveness of immune checkpoint inhibitors (ICIs). METHODS: Patients diagnosed with ovarian SCC at Peking Union M…

2025
doi:10.3802/jgo.2025.36.e8 ·PMID:39900341

ObjectiveThe impact of prophylactic salpingectomy on the prevention of epithelial ovarian cancer (EOC) remains unclear, particularly in Asian populations where data is lacking. In this systematic review and meta-analysis study, we sought to…

2025
doi:10.3802/jgo.2025.36.e126 ·PMID:40517019

ObjectiveTo address the relation among pelvic inflammatory disease (PID), genetic vulnerability and ovarian cancer (OC) risk, we assessed the association between PID and OC risk, alongside the interplay with germline homologous recombinatio…

2025
doi:10.3802/jgo.2025.36.e15 ·PMID:39028150

ObjectiveTo investigate the prevalence of pathological findings and clinical outcomes of risk-reducing salpingo-oophorectomy (RRSO) in asymptomatic carriers with germline homologous recombination repair (HRR) gene pathogenic/likely pathogen…

2024
doi:10.3802/jgo.2024.35.e106 ·PMID:38789396

BackgroundFertility preserving therapy using medroxyprogesterone acetate (MPA) is an important option for young patients with endometrial cancer or atypical endometrial hyperplasia (AEH). However, the effectiveness and feasibility of repeat…

2024
doi:10.3802/jgo.2024.35.e69 ·PMID:38606821

ObjectiveOvarian clear cell carcinoma (OCCC) is associated with chemoresistance. Limited data exists regarding the efficacy of targeted therapies such as immune checkpoint inhibitors (ICI) and bevacizumab, and the role of secondary cytoredu…

2024
doi:10.3802/jgo.2024.35.e80 ·PMID:38670560

ObjectiveTo investigate the efficacy of cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) in predicting survival outcomes based on breast cancer gene (BRCA) mutational status in epithelial ovarian cancer.MethodsMedical records…

2023
doi:10.3802/jgo.2023.34.e6 ·PMID:36245225

ObjectiveElucidation of clonal origin of synchronous endometrial and ovarian cancers (SEOs).MethodsWe reviewed 852 patients who diagnosed endometrial and/or ovarian cancer. Forty-five (5.3%) patients were diagnosed as SEOs. We evaluated blo…

2023
doi:10.3802/jgo.2023.34.e85 ·PMID:37593813

IntroductionMany advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now ava…

2023
doi:10.3802/jgo.2023.34.e1 ·PMID:36245222

ObjectivePreviously, we reported that insulinoma-associated protein 1 (INSM1) immunohistochemistry (IHC) showed high sensitivity for neuroendocrine carcinoma of the uterine cervix and was an effective method for histopathological diagnosis,…

2023
doi:10.3802/jgo.2023.34.e80 ·PMID:37477103

ObjectiveThis study evaluated the feasibility and outcomes of pneumovaginoscopy-assisted radical hysterectomy (PVRH) for cervical cancer up to stage IIA using a bidirectional fascia-oriented and nerve-sparing surgical approach.MethodsThis r…

2022
doi:10.3802/jgo.2022.33.e22 ·PMID:35128854

ObjectiveTo compare the diagnostic accuracies of ultrasound and magnetic resonance imaging (MRI) for deep (≥50%) myometrial invasion (DMI) and cervical stromal invasion (CSI) in women with endometrial cancer.MethodsThis was a prospective st…

2022
doi:10.3802/jgo.2022.33.e85 ·PMID:36335988
article 2022
doi:10.3802/jgo.2022.33.e34 ·PMID:35320885

Up to 1% of women with endometriosis develop endometriosis-associated neoplasms [1]. Most endometriosis-associated malignant tumors develop from the ovarian endometriomas, whereas those developing from extragonadal lesions are extremely rar…

2021
doi:10.3802/jgo.2021.32.e83 ·PMID:34431254

ObjectiveTo investigate current evidence on oncological, fertility and obstetric outcomes of patients with stage I cervical cancer of 4 cm or larger undergoing fertility-sparing surgery (FSS).MethodsSystematic review of studies including wo…